Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...

A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...

There were an estimated 263 million cases reported by the World Health Organization in 2023, up from about 248 million cases ...

This could offer a more affordable treatment option due to the low production costs of the three drugs. However, it is yet to be tested in humans. Although lenacapavir has already been approved for ...